The Petri Dish: Sarepta hit with clinical hold, Decibel stock soars


The FDA has placed a clinical hold on a Duchenne muscular dystrophy drug made by Sarepta Therapeutics Inc.

Previous Exclusive: DFW fintech Meritize closes investment to scale student lending platform
Next Public company will close Broward operation, lay off 88 workers ahead of being acquired